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ABSTRACT
Background: Because retinal and cerebral arterioles share similar pathologic processes, retinal
microvascular changes are expected to be markers of cerebral small vessel disease (SVD). To
better understand the role of SVD in cognitive function, we investigated the relationship between
retinal microvascular abnormalities and longitudinal changes in cognitive function in a community-
based study.
Methods: A total of 803 participants underwent 4 cognitive assessments between 1990–1992
and 2004–2006, using the Word Fluency (WF) test, Digit Symbol Substitution (DSS), and De-
layed Word Recall as well as retinal photography in 1993–1995. Covariate adjusted random
effects linear models for repeated measures were used to determine the associations of cognitive
change with specific retinal vascular abnormalities.
Results: Individuals with retinopathy showed declines in executive function and psychomotor
speed, with 1) an average decline in WF of 1.64 words per decade (95% confidence interval [CI]
3.3, 0.02) compared to no decline in those without retinopathy 0.06 (95% CI 0.6, 0.8) and
2) a higher frequency of rapid decliners on the DSS test.
Conclusion: Signs of retinal vascular changes, as markers of the cerebral microvasculature,
are associated with declines in executive function and psychomotor speed, adding to the
growing evidence for the role of microvascular disease in cognitive decline in the elderly.
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GLOSSARY
ARIC  Atherosclerosis Risk in Communities; AV  arteriovenous; BP  blood pressure; CES-D  Center for Epidemiologic
Studies–Depression scale; CI  confidence interval; CRAE  central retinal artery equivalent; CRVE  central retinal vein
equivalent; DSS  digit symbol substitution; DWR  delayed word recall; MABP  mean arterial blood pressure; SVD  small
vessel disease; WF  word fluency.
Historically, the term vascular dementia has been used to describe a stepwise deterioration in
cognitive function following large vessel clinical strokes often termed multi-infarct dementia.1,2
Recently, studies with newer MRI techniques, or extensive pathologic evaluation, have led to
consensus on the greater importance of cerebral small vessel disease (SVD) in the development
of cognitive impairment.3-6
A noninvasive alternative method to study cerebral SVD involves evaluation of retinal blood
vessels with standardized interpretation using retinal photographs.7 Retinal and cerebral arte-
rioles have a common embryologic origin, similar autoregulation and histologic properties,8
and are subject to similar arteriolosclerosis pathology.8-11 We hypothesize, therefore, that reti-
nal vascular markers will be associated with cognitive decline, thus providing an estimate of the
effect on cerebral SVD on cognition. While cross-sectional studies have reported associations
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between retinal vascular abnormalities and
cognitive impairment,12,13 we are not aware of
any other information on cognitive decline.
In the current analysis, we examined pro-
spectively the association of retinal vascular
abnormalities with cognitive decline over 14
years of follow-up in the Atherosclerosis Risk
in Communities (ARIC) Study cohort. We
tested 3 different cognitive domains—word
fluency, digit symbol substitution, and de-
layed word recall—and hypothesized that
word fluency and digit symbol substitution as
tests of executive function and psychomotor
speed would be more sensitive to microvascu-
lar changes than delayed word recall.
METHODS Study population. Participants in this study
were a subset of the ARIC cohort who, over a period of 14 years
between 1990–1992 and 2004–2006, had 4 cognitive assess-
ments (called CA1–CA4), 2 as part of the main ARIC study and
2 as part of an ancillary Brain MRI Study. Details of the ARIC
study sampling and study design have been published.14 Institu-
tional review boards approved the ARIC study, and all partici-
pants provided written informed consent.
The main ARIC study examined 15,792 women and men
age 45 to 64 years from 4 US communities between 1987 and
1989. At the second examination (1990–1992), 14,348 individ-
uals underwent the cognitive testing that provides the baseline
cognitive assessment (CA1) for this report. Retinal photographs
were offered to all 12,887 cohort members at visit 3 (1993–
1995). At that time, a subset of 2,891 participants age 55 or
older from 2 communities, Forsyth County, NC, and Jackson,
MS, were invited to be part of the Brain MRI ancillary study and
had a second cognitive assessment (CA2), and 1,920 completed
the examination. All ARIC participants underwent cognitive
testing (CA3) at visit 4 (1996–1998). All of the 1,920 who com-
pleted cerebral MRI scans in 1993–1995 were invited to a final
cognitive testing (CA4) between 2004 and 2006, 14 years after
CA1, and 1,134 successfully completed CA4, whereas 268 had
died and 518 refused or were ineligible (because of MRI contra-
indications). Those who completed the CA4 visit were more
likely to be women, healthier (less likely to have diabetes, hyper-
tension, and incident stroke) than those excluded, had fewer
retinal abnormalities, and tended to have higher cognitive scores
at CA1. Of the 1,134 individuals who completed CA4, 331 were
missing one or more retinal measurements or data on key covari-
ates, leaving 803 for this study.
Retinal grading and definitions. As described in detail,15,16
retinal photographs were graded by trained, certified graders
masked to participant characteristics. “Any retinopathy” was de-
fined as present if any of the following lesions were detected:
microaneurysms, soft or hard exudates, retinal hemorrhages,
macular edema, intraretinal microvascular abnormalities, venous
beading, new vessels, vitreous hemorrhage, disc swelling, or laser
photocoagulation scars. Focal narrowing and arteriovenous (AV)
nicking were also noted. Retinal arteriolar and venular diameters
were quantified via a computer-assisted technique. The photo-
graphs were digitized, and the diameters of individual arterioles
and venules coursing through a specified zone surrounding the
optic disc were measured. To obtain the central retinal artery
equivalent (CRAE) and central retinal vein equivalent (CRVE),
measurements of individual arterioles and venules were com-
bined according to the following formulas:
Arterioles Wc  0.87Wa
2  1.10Wb
2  0.22WaWb  10.76
1/2
Venules Wc  0.72Wa
2  0.91Wb
2  450.051/2
In which Wc is the caliber of the trunk vessel, Wa is the caliber of
the smaller branch, and Wb is the caliber of the larger branch.
Pairing of vessels was done arbitrarily combining the largest with
the smallest vessel and then the next largest with next smallest
and so on until all vessels were accounted.15 In this study, gener-
alized arteriolar narrowing was defined as the lowest 25% of the
CRAE distribution (cutoff value of 154 m). Venular widening
was defined as the largest 25% of the CRVE distribution (cutoff
value of 206.5 m). Intragrader and intergrader K statistics were
0.89 and 0.76 for retinopathy, 0.64 and 0.59 for AV nicking,
and 0.58 and 0.44 for focal narrowing, and intraclass correlation
coefficients (the proportions of the total variance due to
between-individual variance) were 0.80 and 0.68 for CRAE and
0.84 and 0.73 for CRVE.17
Cognitive function tests. Participants were administered 3
neuropsychological tests at the 4 time points, CA1–CA4: the
Delayed Word Recall Test (DWR), Word Fluency Test (WF),
and Digit Symbol Substitution Test (DSS).18 The DWR is a test
of verbal learning and recent memory that requires recall of 10
common nouns after a 5-minute interval during which another
test is given. Test-retest reliability over 6 months has been re-
ported to be 0.75 in normal elderly individuals.18 The DSS re-
quires timed translation of numbers to symbols using a key. It
measures psychomotor speed and is relatively unaffected by in-
tellectual ability, memory, or learning. It is scored as the total
number of numbers correctly translated to symbols within 90
seconds.19 Test-retest reliability over 2–5 weeks has been re-
ported as 0.82 in middle-aged persons. The WF test is a measure
of executive functioning, assessing the spontaneous production
of words beginning with a given letter. Participants are asked to
generate as many words as possible beginning with 3 letters and
given 60 seconds for each letter. The score is the total number of
acceptable words produced. Test-retest reliability is high (0.74)
for up to 5 years in older adults.20
Definition of other variables. Cardiovascular risk factors
were measured at CA1 (visit 2). Education was determined at
visit 1 and categorized dichotomously (12 vs 12 years) and
in 3 groups (12, 12–16, and 16 years). Medication usage was
determined at each visit. Diabetes mellitus was defined as a fast-
ing glucose 126 mg/dL, nonfasting glucose of 200 mg/dL,
or self-reported history or current treatment for diabetes. Hyper-
tension was defined as systolic blood pressure 140 mm Hg,
diastolic BP 90 mm Hg, or recent use of antihypertensive
medications. Mean arterial blood pressure (MABP) was calcu-
lated as the average of 1/3 systolic blood pressure (BP)  2/3
diastolic BP at CA1 and CA2. Cigarette smoking was recorded as
never, former, or current smoker. APOE genotyping was per-
formed with the TaqMan assay (Applied Biosystems, Foster
City, CA) and classified here as presence or absence of an 4
allele.
Prevalent strokes were self-reported, and incident strokes
were verified by an ARIC clinician reviewing abstracted hospital
records.21 At CA4, depressive symptoms were assessed using an
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11-item version of the Center for Epidemiologic Studies–De-
pression scale (CES-D).22
Statistical analysis. Rates of decline for each cognitive test
were distributed approximately normally. To test the association
between each retinal variable and cognitive decline rate, we used
random-effects linear models for repeated measures (PROC
MIXED, SAS software 9.1; SAS Institute, Cary, NC). The basic
model consisted of the retinal variables of interest, age (centered
at 50 years), gender, race (black and non-black), time of
follow-up (converted to per decade change), and interaction of
time with each variable. Thus, the term for time refers to the
10-year change in cognitive score for the reference group, and
the interaction of each variable with time reflects the additional
effect of that variable on the rate of change on cognitive scores.
The final model included cardiovascular risk factors known to be
associated with retinal variables and cognitive change. Because of
the importance of hypertension and diabetes, we ran models us-
ing 2 variables together to control for high BP and diabetes,
namely MABP and the hypertension definition, as well as glu-
cose level and the DM definition. The inclusion of MABP or
glucose level did not alter the association of cognitive decline
with retinal vascular variables, so the dichotomous definitions of
hypertension and DM alone were used in final models.
To evaluate the retinal associations with larger cognitive de-
clines, we defined rapid decliners as individuals who were among
the 10% with the greatest declines, with the following cutoffs
(expressed as a change in test score per decade with the more
negative values indicating steeper declines): DWR test 2.1,
DSS test 9.3, WF test 8.5. For each test, we used logistic
regression to determine the odds of the most rapid cognitive
decline associated with specific retinal variables. Models were
repeated within strata of hypertension and diabetes status.
RESULTS The 14-year follow-up cognitive assess-
ment visit (CA4) was attended by 1,134 participants,
803 of whom had complete data on the retinal variables
and key covariates from the first visit 11–14 years ear-
lier. Table 1 compares the characteristics of the 803 in-
dividuals included to the 331 excluded from analysis.
Those included were slightly younger, less likely to have
hypertension or diabetes, and more likely to be white.
Baseline cognitive test scores (CA1) were similar in the
2 groups. Table 2 shows the average cognitive test scores
and average rate of decline per decade for those exam-
ined on each occasion.
After adjustment for age, sex, race, field center,
diabetes, hypertension, smoking, and APOE 4 al-
lele, cognitive scores on the WF test declined more in
persons with than in those without retinal abnormal-
ities (table 3). This difference was significant for any
retinopathy, for retinal microaneurysms specifically,
and for retinal focal arteriolar narrowing. The results
were similar in a more limited model adjusted only
for age, sex, race, and field center (data not shown).
Retinopathy and focal narrowing were still associated
with greater decline in mean WF scores in persons
who were either not diabetic (16 with retinopathy) or
not hypertensive (30 with retinopathy). These associ-
ations were found to be in the same direction,
though not significant, in the smaller sample of per-
sons with diabetes or with hypertension. Retinal ab-
normalities were not associated with significant
declines in mean DWR or DSS scores. On the WF
Table 1 Baseline characteristics of the Atherosclerosis Risk in Communities
study population, 1990 –1992, who were included in or excluded













Age, y 58.7 58.4 59.6 0.01
Men, % 38 40 35 0.39
Black, % 52 49 61 0.01
Education >12 y, % 77 78 75 0.59
Hypertension, % 36 33 44 0.03
Smoker (current), % 17 18 14 0.21
Diabetes, % 10 8 14 0.03
APOE 4 carriers, %† 32 31 36 0.39
CA1 visit year 1992–1994
WF test 32.7 32.9 32.2 0.38
DSS test 40.0 40.4 39.0 0.07
DWR test 6.6 6.6 6.5 0.71
*Significant at p  0.05.
†Percent of participants with either 1 or 2 4 alleles.
CA  cognitive assessment examination; WF  word fluency; DSS  digit symbol substitu-
tion; DWR  delayed word recall.
Table 2 Cognitive scores among Atherosclerosis Risk in Communities participants who underwent repeated







(1993–1995) CA3 (1996 –1998) CA4 (2004 –2006)
Average cognitive
decline per decade
No. Mean SD No. Mean SD No. Mean SD No. Mean SD No. Mean SD
Word Fluency 802 33.1 12.4 794 33.0 12.8 758 33.5 13.0 797 31.6 12.5 797 1.20 5.5
Digit Symbol
Substitution
801 41.0 13.8 794 40.6 14.7 757 40.7 14.2 794 37.1 13.3 794 3.17 5.2
Delayed Word
Recall
803 6.6 1.4 798 6.6 1.5 758 6.7 1.6 799 5.9 1.8 799 0.55 1.3
CA  cognitive assessment examination.
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test, over 14 years of follow-up, the reference group
without retinal abnormalities had no decline in score,
whereas those with specific retinal changes demon-
strated substantial and significant declines in mean
score (figure).
For rapid decliners, the DSS test demonstrated an
association with retinopathy, with an OR of 2.18 (CI
1.02–4.64) (table 4).
Neither the lowest quartile of arteriolar diameter
nor the largest quartile of venular diameter was asso-
ciated with cognitive declines (data not shown). Ar-
teriolar and venular diameters also failed to show
significant associations with cognitive decline when
they were analyzed as continuous variables.
As education (classified either dichotomously or
in 3 groups) was not significantly associated with ei-
ther cognitive decline or retinal variables, it was not
included in final models. We repeated the analyses
excluding individuals with prevalent and incident
stroke, those taking CNS-altering medications at ei-
ther the baseline visit or CA4, those with depressive
symptoms at CA4, and those with low cognitive
scores (lowest 5%) at CA1. None of the associations
reported was substantially altered by these exclusions.
We also repeated the analyses for subgroups strat-
ified by age (60 vs 60 years at baseline), gender,
and race. Lacking a priori hypotheses, we considered
interactions significant only if p  0.01. None met
this level of significance.
DISCUSSION In this prospective, population-based
study, we found that retinopathy and focal retinal
arteriolar narrowing in middle age were associated
with significant declines in mean WF scores. In fact,
in the reference group, i.e., women without retinop-
athy aged 50 years at baseline who did not smoke or
have hypertension or diabetes, WF scores remained
stable, whereas in risk factor-adjusted analyses, those
with retinopathy demonstrated an average loss of 1.7
words per decade. For the DSS test, retinopathy was
associated with rapid cognitive decline (OR  2.18).
The retinal vascular signs studied are associated
with diabetes and elevated blood pressure, which are
established risk factors for cerebrovascular disease, es-
pecially the microvasculature.9,23,24 Of note, retinop-
athy is not just a disease of diabetes; 57% of ARIC
participants with incident retinopathy signs did not
have diabetes.25 The retinal-cognitive associations we
found were not attenuated after adjusting for vascu-
lar risk factors and, despite smaller numbers, re-
mained significant in those who did not have
hypertension or did not have diabetes. The indepen-
dence of these associations suggests that the degree of
microvascular damage, rather than the risk factors
underlying that pathology, is the more direct cause of
Table 3 Ten-year change in scores on Word Fluency Test (WF), Digit Symbol
Substitution Test (DSS), and Delayed Word Recall Test (DWR) by
select retinal characteristics measured at baseline in 1,134
Atherosclerosis Risk in Communities men and women followed
from 1990 –1992 until 2004 –2006
Test and retinal
finding
Mean* 95% CI Difference 95% CI
WF
Retinopathy
Absent 0.06 0.6, 0.8 1.70† 3.2, 0.2
Present 1.64 3.3, 0.02
Focal narrowing
Absent 0.23 0.5, 0.9 1.15† 2.2, 0.1
Present 0.93 2.0, 0.2
AV nicking
Absent 0.10 0.6, 0.8 0.50 1.6, 0.6
Present 0.40 1.6, 0.8
Generalized
narrowing‡
Absent 0.25 0.5, 1.0 0.67 1.6, 0.2
Present 0.42 1.3, 0.5
DSS
Retinopathy
Absent 3.46 4.2, 2.8 0.85 2.4, 0.7
Present 4.31 6.0, 2.8
Focal narrowing
Absent 3.49 4.5, 2.3 0.11 0.9, 1.1
Present 3.38 4.2, 2.8
AV nicking
Absent 3.43 4.1, 2.7 0.37 1.5, 0.7
Present 3.81 5.0, 2.6
Generalized
narrowing
Absent 3.63 4.4, 2.9 0.49 0.4, 1.4
Present 3.14 4.1, 2.2
DWR
Retinopathy
Absent 0.34 0.5, 0.2 0.16 0.5, 0.2
Present 0.50 0.8, 0.2
Focal narrowing
Absent 0.33 0.6, 0.1 0.04 0.2, 0.2
Present 0.37 0.5, 0.2
AV nicking
Absent 0.33 0.5, 0.2 0.03 0.2, 0.2
Present 0.37 0.6, 0.1
Generalized
narrowing
Absent 0.38 0.5, 0.2 0.08 0.1, 0.3
Present 0.30 0.5, 0.2
*Means adjusted for age (years), sex, race, field center, diabetes, hypertension, cigarette
smoking (ever, former, or never), and APOE 4 (1 or 2 alleles vs none).
†Significant at p  0.05.
‡Generalized narrowing defined as central retinal artery equivalent 25th percentile.
CI  confidence interval; AV  arteriovenous.
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the cognitive decline. Retinopathy signs, particularly
microaneurysms, hemorrhages, and soft exudates, are
believed to be the results of microvascular closure
and loss of vascular integrity.26 These ischemic pro-
cesses are likely in turn to damage the retinal tissues
supplied.11,26 As retinal and brain microvasculature
share common physiology and embryology, these
retinal changes provide an indirect indicator of simi-
lar changes in the brain microvasculature, and the
association we found between retinal changes and
cognitive decline may also be interpreted as evidence
of an ischemic effect. As our findings were not atten-
uated after excluding persons with recognized clinical
strokes, ischemia from unrecognized cerebral SVD
would appear to be the reasonable mechanistic inter-
pretation of the cognitive associations we found.
To date, information about the microvascular
contributions to cognitive impairments has arisen
primarily from pathologic and brain imaging studies.
MRI signs of cerebral SVD are consistently associ-
ated with cognitive impairment, even in persons with
AD.27-29 However, pathologic and imaging studies
have their limitations. Lacunar infarcts and white
matter disease are common in elderly persons with-
out cognitive impairment,30 and microscopic infarcts
that affect cognition are not visualized by currently
available neuroimaging techniques, so there are still
no accepted standards for the lesion load seen on
imaging that can unambiguously characterize a per-
son’s cognitive impairment as vascular in origin.31
Microinfarcts, detectable only by direct microscopic
examination of the brain,5 appear to contribute im-
portantly to vascular dementia.4,5 But microinfarcts
have been studied only recently, and it is not yet clear
how to assess them adequately. Retinal vascular ab-
normalities have been shown to be strongly associ-
ated with lacunar infarcts, cerebral atrophy, and
white matter hyperintensities,16,32 and in addition
they share similar histologic properties with cerebral
microvasculature; thus knowledge of their associa-
tions with cognitive change represents useful knowl-
edge that may be added to that gained from imaging
and pathology studies.
Cerebral SVD preferentially affects white matter
and subcortical gray matter (thalamus and basal gan-
glia), with disruption of frontal-subcortical circuits.
This results in difficulties with attention, planning,
and response times for complex tasks, the hallmarks
of executive function deficits.33,34 The greatest cogni-
tive deficits in persons with cerebral SVD are seen in
executive function and processing speed,35,36 rather
than episodic memory, which is more related to
AD.28,33 This SVD pattern was evident in the Rotter-
dam Study, where WMH and silent infarcts mea-
sured by MRI were associated with declines in
processing speed and executive function.28 Our study
employed 3 relevant cognitive tests. The WF test is
believed to be a sensitive test of frontal lobe damage
with deficits in executive functioning.37 The DSS test
is a measure of psychomotor speed and executive
function and has been demonstrated to show im-
pairment in vascular dementias.33 The fact that
these were the 2 tests we found associated with
retinal abnormalities further supports the idea that
retinal vascular changes predict the cognitive im-
pairment which is specifically microvascular in or-
igin. In contrast, we failed to find any association
with decline in DWR, a test of memory more typ-
ically affected in AD.38
Figure Ten-year change in word fluency score in individuals with and without
retinal abnormalities
*p value 0.05. AV  arteriovenous.
Table 4 Multivariate-adjusted odds ratio (OR) for cognitive impairment* in




OR 95% CI OR 95% CI OR 95% CI
Retinopathy 1.01 0.412.52 2.18† 1.024.64 1.33 0.583.07
Focal narrowing 1.55 0.852.83 1.65 0.932.9 0.95 0.481.87
AV nicking 0.77 0.371.61 1.42 0.752.7 0.73 0.341.6
Generalized narrowing‡ 1.10 0.631.93 0.95 0.541.7 1.0 0.551.8
*Cognitive impairment defined as the greatest 10% rate of decline in rate of cognitive
function. Adjusted for age, sex, race, center, hypertension, smoking, APOE 4 allele, and
diabetes.
†p  0.05.
‡Generalized narrowing defined as central retinal artery equivalent 25th percentile.
CI  confidence interval; WF  word fluency; DSS  digit symbol substitution; DWR 
delayed word recall.
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Two previous cross-sectional reports have shown
associations of retinal vascular abnormalities with
cognitive impairment.12,13 Interestingly, unlike our
study, cross-sectional associations from the ARIC
study were somewhat stronger for DWR than for
DSS or WF.12 This inconsistency may pertain to the
advantage of studying change in cognitive function
over time. In a healthy young cohort, cognitive func-
tion is relatively stable and is heavily influenced by
extrinsic factors such as socioeconomic status and ed-
ucation. However, longitudinal analysis tends to re-
duce the influence of extrinsic factors that cannot be
completely accounted for with multivariate model-
ing. Indeed, we, like others,39 found no association of
cognitive decline with educational level. Cognitive
change is a better measure of currently progressing
disease processes, and longitudinal analysis may ex-
plain why WF and DSS, as expected, were most
strongly associated with retinopathy in the current
report.
The study has several potential limitations. The
exclusion of persons who tended to be black, dia-
betic, and older, and to have more retinal abnormal-
ities, threatens the study’s generalizability. However,
except for DSS, baseline mean test scores did not
differ significantly between excluded and included
groups. Patients lost to follow-up also tended to be
older, black, hypertensive, and diabetic, but this may
have made the associations we found conservative.
The imprecision of retinal measurements results in
nondifferential misclassification, which is also likely
to attenuate the retinal associations we found. Severe
proliferative retinopathy can produce visual impair-
ment that could influence cognitive performance;
however, this is unlikely to have affected our study
(particularly the WF test): none of the participants
had proliferative retinopathy, and of those with reti-
nopathy, 90% had fewer than 5 microaneurysms and
70% had fewer than 4 retinal hemorrhages.
Our study findings suggest that retinopathy (a
few small retinal microaneurysms or blot hemor-
rhages) and focal retinal arteriolar narrowing are in-
dices of the type of cerebral vascular abnormalities
which affect cognition in elderly persons. Of course,
ongoing MRI studies will provide complementary
information using a different modality. Our findings
support the need for research on the potential cost-
effectiveness of ophthalmoscopy in identifying per-
sons with unexplained cognitive impairment who
might benefit from risk reduction modification.
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